OTLC OTC
Oncotelic Therapeutics, Inc.
1W: -17.0%
1M: -40.7%
3M: -49.9%
YTD: -73.0%
1Y: -69.5%
3Y: -30.0%
5Y: -83.8%
$0.02
-0.00 (-1.41%)
Weekly Expected Move ±11.9%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$247M
Net Income
+6403.6% YoY
$-2M
Free Cash Flow
-182.2% YoY
100.0%
Gross Margin
-337.4%
Op. Margin
155.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE0.0%
ROA0.0%
ROIC-0.0%
Valuation
P/E0.0
P/B0.0
EV/EBITDA-31.9
Leverage
Debt/Equity0.06
Current Ratio0.08
Interest Cov.-5.6x
Quality Scores
Piotroski F5/9
Altman Z-0.05
Beneish M0.00